Gemphire Therapeutics Inc. Uncategorized Contracts & Agreements

28 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment to Membership Agreement, dated December 14, 2022 by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2023
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2023
Amendment to Membership Agreement, dated August 30, 2022, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Lock-Up Agreement to be executed by entities affiliated with E&Investment, Inc
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Lock-Up Agreement to be executed by Dong-A ST Co. Ltd and Roy Lester Freeman
Gemphire Therapeutics Inc.
Biotechnology
2022
Form of Leak-Out Agreement
Gemphire Therapeutics Inc.
Biotechnology
2022
Amendment to Membership Agreement, dated April 19, 2022, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Amendment to Membership Agreement, dated February 9, 2022, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
Amendment to Membership Agreement, dated December 23, 2021, by and between WeWork and the Registrant
Gemphire Therapeutics Inc.
Biotechnology
2022
NeuroBo Pharmaceuticals, Inc. 2021 Inducement Plan
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated May 14, 2021
Gemphire Therapeutics Inc.
Biotechnology
2021
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2021
First Amendment to Contingent Value Rights Agreement, dated as of December 30, 2019, by and among NeuroBo, the Holders Representative, and the Rights Agent, dated as of March 23,...
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Form of Lock-Up Agreement
Gemphire Therapeutics Inc.
Biotechnology
2021
Form of Support Agreement
Gemphire Therapeutics Inc.
Biotechnology
DE
2021
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated November 11, 2020
Gemphire Therapeutics Inc.
Biotechnology
2020
Offer Letter, dated as of January 29, 2020, by and between Nicola Shannon and NeuroBo Pharmaceuticals, Inc
Gemphire Therapeutics Inc.
Biotechnology
2020
Membership Agreement by and between WeWork and NeuroBo Pharmaceuticals, Inc., dated January 9, 2020
Gemphire Therapeutics Inc.
Biotechnology
NY
2020
Description of Securities
Gemphire Therapeutics Inc.
Biotechnology
2020
Offer Letter, dated as of August 20, 2018, by and between Nicola Shannon and NeuroBo
Gemphire Therapeutics Inc.
Biotechnology
2019
Contingent Value Rights Agreement, dated as of December 30, 2019, by and among the Company, Grand Rapids Holders Representative, LLC, Computershare Inc. and Computershare Trust...
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Acquisition Agreement by and between Dong-A ST Co., Ltd. and NeuroBo Pharmaceuticals, Inc., dated January 18, 2018, as amended on April 18, 2018 and July 24, 2019
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Fourth Amended and Restated Stockholders' Agreement, by and among the Initial Holders and the Investors on Schedule A thereto and NeuroBo Pharmaceuticals, Inc., dated May 30, 2019
Gemphire Therapeutics Inc.
Biotechnology
DE
2019
Independent Contractor Agreement by and between Therabo PLLC and NeuroBo Pharmaceuticals, Inc., dated March 1, 2019
Gemphire Therapeutics Inc.
Biotechnology
MA
2019
AMENDMENT No. 1 TO THE Gemphire Therapeutics Inc. INDUCEMENT PLAN
Gemphire Therapeutics Inc.
Biotechnology
2018
Offer Letter between Gemphire Therapeutics Inc. and Dr. Steve Gullans dated June 8, 2017
Gemphire Therapeutics Inc.
Biotechnology
2017
GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN OPTION GRANT NOTICE
Gemphire Therapeutics Inc.
Biotechnology
2016
GEMPHIRE THERAPEUTICS INC. INDUCEMENT PLAN APPROVED BY THE BOARD OF DIRECTORS ON: September 30, 2016
Gemphire Therapeutics Inc.
Biotechnology
DE
2016